Correction to: Eye (2017) 31, 1409–1416; doi: 10.1038/eye.2017.73; published online 28 April 2017
Since the online publication of the above article, the authors have noted that the manufacturer of Vismed Multi was cited incorrectly. The correct manufacturer is TRB Chemedica International S.A., Geneva, Switzerland.
The authors apologise for any inconvenience caused by this error.
This error has now been rectified, and the corrected article appears in this issue. The html and online pdf versions have also been rectified, and now carry the corrected paper.
Additional information
The online version of the original article can be found at 10.1038/eye.2017.73
Rights and permissions
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/
About this article
Cite this article
Labetoulle, M., Chiambaretta, F., Shirlaw, A. et al. Erratum: Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye. Eye 31, 1512 (2017). https://doi.org/10.1038/eye.2017.124
Published:
Issue Date:
DOI: https://doi.org/10.1038/eye.2017.124
